Currently, there are 324.27M common shares owned by the public and among those 324.26M shares have been available to trade.
The company’s stock has a 5-day price change of -1.45% and -11.73% over the past three months. BILI shares are trading -16.52% year to date (YTD), with the 12-month market performance down to -55.06% lower. It has a 12-month low price of $8.80 and touched a high of $25.58 over the same period. BILI has an average intraday trading volume of 6.12 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 1.59%, -1.15%, and -25.78% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Bilibili Inc ADR (NASDAQ: BILI) shares accounts for 17.64% of the company’s 324.27M shares outstanding.
It has a market capitalization of $3.29B and a beta (3y monthly) value of 0.97. The earnings-per-share (ttm) stands at -$1.74. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.52% over the week and 4.05% over the month.
Analysts forecast that Bilibili Inc ADR (BILI) will achieve an EPS of -$0.22 for the current quarter, -$0.17 for the next quarter and -$0.24 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.28 while analysts give the company a high EPS estimate of -$0.18. Comparatively, EPS for the current quarter was -$0.48 a year ago. Earnings per share for the fiscal year are expected to increase by 47.55%, and 75.27% over the next financial year.
UBS coverage for the Bilibili Inc ADR (BILI) stock in a research note released on December 04, 2023 offered a Neutral rating with a price target of $13.20. Mizuho on their part issued Buy rating on November 06, 2023.
